Study type

Study topic

Human medicinal product
Disease /health condition

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(G04BE03) sildenafil
sildenafil

Medical condition to be studied

Erectile dysfunction
Population studied

Short description of the study population

Pharmacists who have received at least one patient request to supply Viagra Connect within the six months preceding the survey administration.
Pharmacists must meet all of the following inclusion criteria:
1. Willing/consent to participate in this self-administered survey (Answered “Yes” to a survey question asking “Do you agree to proceed with this survey”);
2. A practicing pharmacist in the UK;
3. Received at least one patient face-to-face request to supply Viagra Connect in the past six months.

Age groups

  • Adult and elderly population (≥18 years)
    • Adults (18 to < 65 years)
      • Adults (18 to < 46 years)
      • Adults (46 to < 65 years)
    • Elderly (≥ 65 years)
      • Adults (65 to < 75 years)
      • Adults (75 to < 85 years)
      • Adults (85 years and over)

Estimated number of subjects

200
Study design details

Main study objective

To evaluate the effectiveness of the Viagra Connect national aRMM by assessing: • The pharmacists’ knowledge of the key risk messages contained in the Viagra Connect training materials, • The pharmacists’ participation in the Viagra Connect pharmacist training,• The pharmacists’ utilisation of the optional Viagra Connect Pharmacy Checklist at the point of dispensing.

Data analysis plan

Data collected from the survey will be reported as descriptive statistics. No statistical inferences will be made. Frequency distributions with 95% confidence intervals (CIs) will be calculated for pharmacist’s responses to all questions that address the survey objectives. Survey data will be stratified by participating in the training and by other key pharmacist’s characteristics if sample sizes are large enough (ie, no less than 25 in the minority group).